Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.

Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions ...

Paul Romness had over two decades of experience as a public and policy affairs expert when his daughter’s best friend’s osteosarcoma diagnosis inspired a new career trajectory.

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug ...

A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

Life sciences companies face challenges transitioning from R&D to clinical trials due to outdated, fragmented technology systems that struggle to support the complexity of later trial phases.

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or two days. Customers now expect their healthcare experience to be similarly ...

It’s not as much of a stretch as you might think. I’ve always loved bikes. In my early 20s, I was a competitive athlete in ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...